Clinical Trial Update: PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients

View source ↗

Summary

A completed clinical trial update from AstraZeneca on PROstaTE cancer treatment and obesity in patients treated with Zoladex.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Prostate Cancer

Drugs mentioned

• Zoladex (goserelin)

Snippet

Sponsor: AstraZeneca | Conditions: Prostate Cancer, Obesity | Status: COMPLETED